| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | vitamin D3 25-hydroxylase activity | 1.19e-04 | 6 | 57 | 2 | GO:0030343 | |
| GeneOntologyMolecularFunction | vitamin D 25-hydroxylase activity | 1.67e-04 | 7 | 57 | 2 | GO:0070643 | |
| GeneOntologyMolecularFunction | dinucleotide phosphatase activity | 2.85e-04 | 9 | 57 | 2 | GO:0004551 | |
| Domain | Cyt_P450_E_grp-I | 6.97e-03 | 45 | 52 | 2 | IPR002401 | |
| Domain | Cyt_P450_CS | 9.57e-03 | 53 | 52 | 2 | IPR017972 | |
| Domain | fn3 | 1.04e-02 | 162 | 52 | 3 | PF00041 | |
| Pathway | REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS | 9.38e-07 | 71 | 36 | 5 | M1078 | |
| Pathway | REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT | 1.70e-06 | 80 | 36 | 5 | M6121 | |
| Pathway | REACTOME_COMPLEMENT_CASCADE | 1.02e-05 | 115 | 36 | 5 | M19752 | |
| Pathway | REACTOME_CD22_MEDIATED_BCR_REGULATION | 1.69e-05 | 61 | 36 | 4 | M27581 | |
| Pathway | REACTOME_FCGR_ACTIVATION | 2.75e-05 | 69 | 36 | 4 | M27108 | |
| Pathway | REACTOME_SCAVENGING_OF_HEME_FROM_PLASMA | 2.75e-05 | 69 | 36 | 4 | M27150 | |
| Pathway | REACTOME_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION | 3.08e-05 | 71 | 36 | 4 | M27203 | |
| Pathway | REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS | 5.44e-05 | 82 | 36 | 4 | M27110 | |
| Pathway | REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION | 6.55e-05 | 86 | 36 | 4 | M27206 | |
| Pathway | REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS | 6.55e-05 | 86 | 36 | 4 | M601 | |
| Pathway | REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION | 6.86e-05 | 87 | 36 | 4 | M27205 | |
| Pathway | REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS | 9.66e-05 | 95 | 36 | 4 | M29842 | |
| Pathway | REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS | 1.09e-04 | 98 | 36 | 4 | M27152 | |
| Pathway | REACTOME_PARASITE_INFECTION | 2.09e-04 | 116 | 36 | 4 | M29843 | |
| Pathway | REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION | 3.63e-04 | 134 | 36 | 4 | M29840 | |
| Pathway | REACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION | 3.84e-04 | 136 | 36 | 4 | M27207 | |
| Pathway | REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS | 4.65e-04 | 143 | 36 | 4 | M27107 | |
| Pathway | REACTOME_POTENTIAL_THERAPEUTICS_FOR_SARS | 6.15e-04 | 154 | 36 | 4 | M39007 | |
| Pathway | REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR | 8.14e-04 | 166 | 36 | 4 | M608 | |
| Pathway | REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING | 1.24e-03 | 186 | 36 | 4 | M27175 | |
| Pathway | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | 1.34e-03 | 190 | 36 | 4 | M8240 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_SPECIALIZED_PRORESOLVING_MEDIATORS_SPMS | 1.42e-03 | 22 | 36 | 2 | MM15614 | |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | 1.45e-03 | 194 | 36 | 4 | M16312 | |
| Pathway | REACTOME_LEISHMANIA_INFECTION | 2.26e-03 | 219 | 36 | 4 | M29836 | |
| Pubmed | 8.18e-07 | 43 | 58 | 4 | 1249422 | ||
| Pubmed | 1.18e-06 | 47 | 58 | 4 | 814163 | ||
| Pubmed | One-megabase sequence analysis of the human immunoglobulin lambda gene locus. | 3.40e-05 | 109 | 58 | 4 | 9074928 | |
| Pubmed | 7.22e-05 | 48 | 58 | 3 | 11955599 | ||
| Pubmed | Sequence and evolution of the human germline V lambda repertoire. | 7.68e-05 | 49 | 58 | 3 | 8951372 | |
| Pubmed | Role of the Drug-Metabolizing Enzyme CYP during Mouse Liver Development. | 1.49e-04 | 11 | 58 | 2 | 27904043 | |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | 2.02e-04 | 1242 | 58 | 9 | 30973865 | |
| Pubmed | 2.33e-04 | 332 | 58 | 5 | 37433992 | ||
| Pubmed | Characterization of vertebrate cohesin complexes and their regulation in prophase. | 2.46e-04 | 14 | 58 | 2 | 11076961 | |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | 3.51e-04 | 363 | 58 | 5 | 14691545 | |
| Pubmed | 3.66e-04 | 17 | 58 | 2 | 21043528 | ||
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 3.79e-04 | 807 | 58 | 7 | 22681889 | |
| Pubmed | ¹H NMR metabolic profiling of plasma reveals additional phenotypes in knockout mouse models. | 5.09e-04 | 20 | 58 | 2 | 25849460 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 5.21e-04 | 608 | 58 | 6 | 36089195 | |
| Pubmed | 5.90e-04 | 407 | 58 | 5 | 12693553 | ||
| Pubmed | 1.08e-03 | 29 | 58 | 2 | 23396134 | ||
| Pubmed | 1.11e-03 | 469 | 58 | 5 | 37314180 | ||
| Pubmed | 1.14e-03 | 274 | 58 | 4 | 34244482 | ||
| Pubmed | 1.28e-03 | 723 | 58 | 6 | 34133714 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | 1.29e-03 | 724 | 58 | 6 | 36232890 | |
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | 1.39e-03 | 289 | 58 | 4 | 23752268 | |
| Cytoband | 3q13.1 | 1.56e-05 | 5 | 58 | 2 | 3q13.1 | |
| Cytoband | 22q11.2 | 1.69e-05 | 120 | 58 | 4 | 22q11.2 | |
| GeneFamily | Immunoglobulin lambda locus at 22q11.2 | 3.96e-05 | 89 | 39 | 4 | 353 | |
| Coexpression | GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_DN | 4.33e-06 | 200 | 56 | 6 | M3405 | |
| ToppCell | healthy_donor-Lymphocytic-Plasma_cell-IgM_Plasmablast|healthy_donor / Disease condition, Lineage, Cell class and subclass | 2.52e-06 | 166 | 58 | 5 | 2b7b580bec8d9467b0deaf97098065f72dbf2a4f | |
| ToppCell | Control-Lymphoid_P|Control / Disease group, lineage and cell class | 3.35e-06 | 176 | 58 | 5 | d895a6b295cd649273ff80ad7785a3e0ae4c728a | |
| ToppCell | Control-Lymphoid_P-Plasmablast|Control / Disease group, lineage and cell class | 3.35e-06 | 176 | 58 | 5 | 4b4416f342b732d2cc60133838728880326257d8 | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.45e-06 | 177 | 58 | 5 | 4c434a7b7cc54cf4dac996bbc3f5124d9ef9a9cd | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.45e-06 | 177 | 58 | 5 | fc40918825b7e1eb6861df59dfca944778a64b98 | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.45e-06 | 177 | 58 | 5 | d746122bf8d208c3aa4d156e8c12d0a0e555c6e5 | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.64e-06 | 179 | 58 | 5 | 837ed81f18257f444eaeadc4fac89deedd4e3061 | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.64e-06 | 179 | 58 | 5 | 494febe77c6d4e6a2c6f0928bbf4c84b0301f188 | |
| ToppCell | 10x5'-Lung-Lymphocytic_B_plasma-Plasmablasts|Lung / Manually curated celltypes from each tissue | 3.64e-06 | 179 | 58 | 5 | 3fa75eec3e86fd1797eaa33362257df7f9b2a0bf | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.64e-06 | 179 | 58 | 5 | b6ee4f41d8fb5f047b7bdd8489dda0a89fc6d43f | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 4.39e-06 | 186 | 58 | 5 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | healthy_donor-Lymphocytic-Plasma_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 4.62e-06 | 188 | 58 | 5 | bd53b0371154cff680226897b61c9809a239d1b6 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.12e-06 | 192 | 58 | 5 | 0dc1f46e40346ed0b286e53b106a812441575100 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.66e-06 | 196 | 58 | 5 | 2029f58ce6a7b8c35d3a7496c3341391990909ce | |
| ToppCell | COVID_non-vent-Lymphocytic-Plasma_cell-IgA_Plasmablast|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 5.81e-06 | 197 | 58 | 5 | fdbf4eb9fa5aefb4ffb307494fe4774bf5e0aaeb | |
| ToppCell | COVID_vent-Lymphocytic-Plasma_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 5.95e-06 | 198 | 58 | 5 | e84c5f712e1dea548d0e2aba6625598f9671d3a0 | |
| ToppCell | Control-Control-Lymphocyte-B-Plasmablast|Control / Disease, condition lineage and cell class | 6.10e-06 | 199 | 58 | 5 | c11aa8bca3723a886e7082ae48bb922dd8396be4 | |
| ToppCell | Caecum-T_cell-CD8_T|T_cell / Region, Cell class and subclass | 6.25e-06 | 200 | 58 | 5 | 40e435f5dd1a0f6554f87dc1e170a740fd733d5b | |
| ToppCell | healthy_donor-Lymphocytic-Plasma_cell-IgG_Plasmablast|healthy_donor / Disease condition, Lineage, Cell class and subclass | 4.61e-05 | 152 | 58 | 4 | a2ba2d95ac9010e1a62db34dcad10d004f8a90cc | |
| ToppCell | BAL-Mild-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.10e-05 | 156 | 58 | 4 | 5d9e1df70f2e9219f6b029be2e39297605d36726 | |
| ToppCell | BAL-Mild-Lymphocyte-B-Plasmablast-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.36e-05 | 158 | 58 | 4 | 17a13c5719eb363f2eb8f1d4e171429c6a1ce1e9 | |
| ToppCell | BAL-Mild-Lymphocyte-B-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.36e-05 | 158 | 58 | 4 | e5451cfe67e882eb0c1eca287740f8ab75370abc | |
| ToppCell | BAL-Mild-Lymphocyte-B-Plasmablast-Plasmablast-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.36e-05 | 158 | 58 | 4 | 1397078f909338fa5fa3b01748db891e5e3fc9e7 | |
| ToppCell | BAL-Mild-Lymphocyte-B-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.49e-05 | 159 | 58 | 4 | 1827493fb464bbddb2ee23f99472cfbcaf57405b | |
| ToppCell | BAL-Mild-Lymphocyte-B-Plasmablast-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.49e-05 | 159 | 58 | 4 | 6ecc3cb2daa5887b59836842be414a00cdcdaeec | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.49e-05 | 159 | 58 | 4 | 7ed659163f45e0c4df4782997c0786900c8186c8 | |
| ToppCell | Mild-Lymphoid-Plasma-|Mild / Condition, Lineage, Cell class and cell subclass | 5.63e-05 | 160 | 58 | 4 | aa79848913910c01249d6cacf4ed53ec0e4f5c3d | |
| ToppCell | Mild-Lymphoid-Plasma|Mild / Condition, Lineage, Cell class and cell subclass | 5.63e-05 | 160 | 58 | 4 | 7fdb849f5caf5a127a2582326215e11f8eb4fa0e | |
| ToppCell | Mild_COVID-19-B_cell-Plasmablast|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 5.91e-05 | 162 | 58 | 4 | b67f6fb3d7f6093c8ef02398ff8fea4d0fb41a3b | |
| ToppCell | 367C-Lymphocytic-Plasma_cell-|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.64e-05 | 167 | 58 | 4 | f2185eb72f0137136f6d71af2a70168fded6c940 | |
| ToppCell | 367C-Lymphocytic-Plasma_cell|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.64e-05 | 167 | 58 | 4 | 5e768cf24699893e05d1bcb1c92dba2336943a64 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_dendritic-plasmacytoid_dendritic_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.64e-05 | 167 | 58 | 4 | afb6d0993f3fd44a295874673055189d514f7b11 | |
| ToppCell | 10x5'-Lung-Lymphocytic_B_plasma-Plasma_cells|Lung / Manually curated celltypes from each tissue | 6.80e-05 | 168 | 58 | 4 | e8bd090de5c9fe286b08a8b314ce12cf988184f0 | |
| ToppCell | BAL-Mild-Lymphocyte-B|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.96e-05 | 169 | 58 | 4 | 307571e57c3bfdf15f0fe1a8b36585e8e4f8a207 | |
| ToppCell | tumor_Lung-B_lymphocytes-Plasma_cells|tumor_Lung / Location, Cell class and cell subclass | 6.96e-05 | 169 | 58 | 4 | b36b7632ce55fc7b6b8b66020563d360b3de6fd7 | |
| ToppCell | 10x5'-Lung-Lymphocytic_B_plasma|Lung / Manually curated celltypes from each tissue | 7.45e-05 | 172 | 58 | 4 | 8156fb6de66a4c92ade703b71c2e9187291e50ef | |
| ToppCell | COPD-Lymphoid-B_Plasma|World / Disease state, Lineage and Cell class | 7.96e-05 | 175 | 58 | 4 | d73ee324479172501481b54967a0f3bd870fcf3a | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-Plasma_B-Plasma_B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.14e-05 | 176 | 58 | 4 | 67d6dc38708692f8c58cea5ed896f10718e9ffa6 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-Plasma_B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.14e-05 | 176 | 58 | 4 | 125be81311f87563ca321472fcce6e0e0ae24c16 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.32e-05 | 177 | 58 | 4 | c2b0fb5921eea24d248d6e6ccb57c29b0832602c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.32e-05 | 177 | 58 | 4 | 111fb0707ff37ca631d85bb5a09e067ffe568eb8 | |
| ToppCell | Healthy-Plasmablast|Healthy / disease group, cell group and cell class | 8.32e-05 | 177 | 58 | 4 | 4ff75c609ac9edf7a94bda42eb7124c559e8b6aa | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.51e-05 | 178 | 58 | 4 | c77a1d1a9aef0ab51b4408b9e84f201219788ca2 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.88e-05 | 180 | 58 | 4 | cea079bc02e08c46600eed05ab9924ec90e1e3d3 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.27e-05 | 182 | 58 | 4 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.27e-05 | 182 | 58 | 4 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | cellseq-Immune-Lymphocytic_B-Lymphocytic_B-Plasma|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.47e-05 | 183 | 58 | 4 | 5ab4aa0304b832f98fff89b6c24ad5b7dd014c11 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.67e-05 | 184 | 58 | 4 | 15f2c10101ccc8ed059520fc082ee42593dff269 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.67e-05 | 184 | 58 | 4 | a90a58d9e319afa1cd572e4c2f516fadc42f56e5 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-Plasma_B-Plasma_B-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.87e-05 | 185 | 58 | 4 | 96423bdcf0e85ca41370f79347d27c22f3de98f5 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.87e-05 | 185 | 58 | 4 | 08bc817908076734d66f2805cb954141f2cc5a18 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.87e-05 | 185 | 58 | 4 | 0fff2608f507e019ebb69c27e58fd5be3b049bef | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.87e-05 | 185 | 58 | 4 | 79edc1eeb7b5b9123961ac3ecf398ee68d9dddb9 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.87e-05 | 185 | 58 | 4 | 1704a12153a9b107bf03ecccd1a036cf61334d7a | |
| ToppCell | healthy_donor-Lymphocytic-Plasma_cell-IgA_Plasmablast|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.01e-04 | 186 | 58 | 4 | e2c050ba02e1f84f0b7258dc92e7ff6ab349ff67 | |
| ToppCell | COPD-Epithelial-ATII|Epithelial / Disease state, Lineage and Cell class | 1.03e-04 | 187 | 58 | 4 | 030af361f8bdcd0aff4ec1922702833325cf74d8 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.05e-04 | 188 | 58 | 4 | eea652bab161f19148a883e7e3fe2523b36b3cea | |
| ToppCell | COVID-19-kidney-PCT-S2|kidney / Disease (COVID-19 only), tissue and cell type | 1.07e-04 | 189 | 58 | 4 | 0be5c669b6b308bd98ddb70c84877c62a6244bbd | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.09e-04 | 190 | 58 | 4 | 79ee6d10dfbb775da149a1104da5823cf63bbb46 | |
| ToppCell | Control-Endothelial-VE_Venous|Endothelial / Disease state, Lineage and Cell class | 1.09e-04 | 190 | 58 | 4 | 4e30155203b4a8c5e496fcbe9348b67b98ebc625 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells-IgA_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.09e-04 | 190 | 58 | 4 | 18762ce78ed0b206ade19e1c8ff76a2647489f68 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.09e-04 | 190 | 58 | 4 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.12e-04 | 191 | 58 | 4 | d1d30279ed4612b4f62c225d9eabf0b8a7a09d11 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-B_cells-Immature_B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.12e-04 | 191 | 58 | 4 | 8c35fccc4617694eae1e55b1107841ffe7f1bac8 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.14e-04 | 192 | 58 | 4 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.14e-04 | 192 | 58 | 4 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.14e-04 | 192 | 58 | 4 | 3dddfc93c3c954c4416c7c1f1f161e4d1dcc1233 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.14e-04 | 192 | 58 | 4 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.14e-04 | 192 | 58 | 4 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.14e-04 | 192 | 58 | 4 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-04 | 193 | 58 | 4 | 34f6c13884fdf7f8a87f942fcb36a58cfac3f65d | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells-IgG_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.19e-04 | 194 | 58 | 4 | f083777353e76a2d9c39f8b6cb1a689b68b81c56 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.19e-04 | 194 | 58 | 4 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | Control-Epithelial-ATII|Epithelial / Disease state, Lineage and Cell class | 1.19e-04 | 194 | 58 | 4 | a01de094f7bfd099bcbb2f94224690a2efb887b4 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-04 | 195 | 58 | 4 | 938b31dbf1674ee6fd0123bc88391ddcaf151217 | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.21e-04 | 195 | 58 | 4 | 13f4ee21568fd747608412d33559d10561dbb3c8 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-04 | 195 | 58 | 4 | d39e9e6544f49e677ebe528c6fe60b99a3630e30 | |
| ToppCell | 5'-Adult-LargeIntestine|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.21e-04 | 195 | 58 | 4 | 600174e35574fe7c44dd923adcf43686e7b01e39 | |
| ToppCell | COVID_vent-Lymphocytic-Plasma_cell-IgM_Plasmablast|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.23e-04 | 196 | 58 | 4 | 026a06d8d2089806823e6f6453d3ede84ae93bc6 | |
| ToppCell | Biopsy_IPF-Immune-Plasma_cells|Biopsy_IPF / Sample group, Lineage and Cell type | 1.23e-04 | 196 | 58 | 4 | a1b6a8000b86efcb07843998aa3a49bb1f54bcda | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 1.31e-04 | 199 | 58 | 4 | fde2b65afde69f402f1b7b056eaa266e9fd5b227 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.31e-04 | 199 | 58 | 4 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| Disease | visceral adipose tissue measurement | 2.36e-05 | 481 | 53 | 7 | EFO_0004765 | |
| Disease | household income | 2.15e-04 | 304 | 53 | 5 | EFO_0009695 | |
| Disease | cyclic adenosine monophosphate measurement | 4.23e-04 | 17 | 53 | 2 | EFO_0010473 | |
| Disease | neurotic disorder | 8.05e-04 | 101 | 53 | 3 | EFO_0004257 | |
| Disease | lifestyle measurement | 8.46e-04 | 235 | 53 | 4 | EFO_0010724 | |
| Disease | mood instability measurement | 1.59e-03 | 128 | 53 | 3 | EFO_0008475 | |
| Disease | hippocampal volume | 2.00e-03 | 297 | 53 | 4 | EFO_0005035 | |
| Disease | dentate gyrus volume measurement | 2.25e-03 | 39 | 53 | 2 | EFO_0010083 | |
| Disease | unipolar depression, age at onset | 2.36e-03 | 40 | 53 | 2 | EFO_0003761, EFO_0004847 | |
| Disease | hippocampal CA4 volume | 2.48e-03 | 41 | 53 | 2 | EFO_0009396 | |
| Disease | brain measurement, neuroimaging measurement | 3.04e-03 | 550 | 53 | 5 | EFO_0004346, EFO_0004464 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | 3.05e-03 | 801 | 53 | 6 | EFO_0003888, EFO_0007052, MONDO_0002491 | |
| Disease | vitamin D measurement | 3.12e-03 | 336 | 53 | 4 | EFO_0004631 | |
| Disease | risky sexual behaviour measurement | 3.50e-03 | 169 | 53 | 3 | EFO_0007877 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PLTPTLYKMHKGWKN | 196 | Q9NP73 | |
| LKGMASWKQKYEPLG | 366 | Q9UJX5 | |
| LSFWMKHGVTPNKGK | 376 | Q9BQT9 | |
| MKANPGYKWCPTTNK | 141 | Q8WY36 | |
| PFHMKKSSGDWKVQG | 136 | Q5NE16 | |
| KKYGKMWGTYEGQLP | 66 | P20815 | |
| SKGHLPSGMWRQPKD | 211 | A8MVX0 | |
| YRGVKKKMKPPTSWG | 1491 | Q8WZ64 | |
| PKWPSHYLMVPGGKH | 231 | Q9UM07 | |
| AQHVKMGYGAWYLKP | 931 | Q5HY64 | |
| IPDKGKAWGPMYVAK | 316 | Q9H649 | |
| KMYIFGGWVPHKGEN | 256 | Q9Y5Z7 | |
| MKSNGPHPWKQVKGR | 496 | Q6ZRQ5 | |
| WYQQHPGKAPKLMIY | 56 | P01705 | |
| KLKNMWKFPGGLSEP | 166 | P53370 | |
| SPKEGMIKGLWKNHS | 1941 | P50748 | |
| FAKMKGYPHWPARID | 16 | Q9Y3E1 | |
| PGQDKMKSLWPHKAL | 96 | Q96QZ0 | |
| KGLKDMGYGNWISKP | 1201 | P55265 | |
| MWAAKSYPSLKPLGG | 3926 | Q8TD57 | |
| YPPPKVMWKHAKGSG | 716 | Q8TD84 | |
| PNGKPSWDDKCKMPY | 346 | Q6VVX0 | |
| EGLHKLMWIPVYGGK | 651 | Q05707 | |
| KGWKLRYHGDPMPCP | 281 | P09871 | |
| LKPGTGPQDCKWKMY | 446 | Q9NYL2 | |
| AMEKAWAPGGKTNHK | 2031 | O15021 | |
| HPLWKWMKIQPKGKG | 141 | P36969 | |
| LMFGKWKYEKPDGSP | 51 | Q13740 | |
| KKWHAKGFGMTLKGP | 291 | Q8N1G2 | |
| WYQQHPGKAPKLMIY | 56 | P01706 | |
| WYQQHPGKAPKLMIY | 56 | P01704 | |
| GTHKGSLKPHDYPKW | 211 | O14832 | |
| GGDLTHWIYKKYPNM | 311 | Q96HN2 | |
| WYQQHPGKAPKLMIY | 56 | P01709 | |
| KAAKWKNPDGHMDGL | 171 | Q9HAT8 | |
| PGEGSKGHKKISWPY | 11 | Q9NVN8 | |
| WPFLLGHYKFGMSKK | 576 | O43147 | |
| WYHKVRKPGIAMKLP | 26 | Q96LZ7 | |
| GYLKSWPPTKMGLDE | 286 | O00327 | |
| SGTPMPKKYSWFHNG | 316 | Q8IUL8 | |
| PNEFKVYMGHGGKPW | 371 | Q96KP4 | |
| RGDGYLHPVKKWPMR | 121 | Q7RTU0 | |
| MKKKQQHPGGGADPW | 1 | Q9Y2C2 | |
| YKEGMSPSEKPAWAK | 521 | Q9UKE5 | |
| SGDYPLTMAGPQWKK | 156 | Q8N3U4 | |
| LMWKENGKKPGSFPK | 426 | Q6ZQQ2 | |
| KPKWKSDYPMTDGQL | 36 | Q8WUN7 | |
| GMWKKLQEKFAPKGP | 106 | Q9BRT2 | |
| GSRPKKPLGKMADWF | 11 | P58753 | |
| NMAFGKPAKYWKLDP | 96 | Q9H0R3 | |
| GLFAVYKPPGLKWKH | 11 | O95900 | |
| YPEGIKWKFLEHKGP | 211 | P11387 | |
| WPPYTKKMSSKGLSG | 1166 | Q8NDV7 | |
| KIPGGHWRQMIYAPK | 166 | A8MT65 | |
| EWYLPKMAKHLPGVN | 471 | Q9NX78 | |
| TYDMWLKKHNPGKPG | 801 | Q9UGR2 | |
| GNKPEDCPYLWAHMK | 496 | P35573 | |
| KTMRDYGKHVKWPSP | 751 | O94832 | |
| PDHKPKSWVAAEKMY | 1001 | Q9NZM1 |